US Patent Issued to The Rockefeller University, California Institute of Technology on June 24 for "Broadly neutralizing antibodies that target HIV ENV V3 N-glycans" (New York, California Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,338,277, issued on June 24, was assigned to The Rockefeller University (New York) and California Institute of Technology (Pasadena, Calif.).

"Broadly neutralizing antibodies that target HIV ENV V3 N-glycans" was invented by Hugo Mouquet (New York), Michel Nussenzweig (New York), Pamela J. Bjorkman (Altadena, Calif.) and Louise Scharf (Porter Ranch, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to anti-HIV antibodies. Also disclosed are related methods and compositions. HIV causes acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central n...